Pharmafile Logo
Pharmafocus logo
Advanced Search

Omicron could become dominant variant in UK within weeks, expert warns

December 6, 2021
Research and Development

Infectious diseases expert, Professor Paul Hunter, has warned that Omicron could become the UK’s dominant COVID-19 variant within weeks.The UK …

News

UK study shows Pfizer and Moderna jabs give best COVID-19 protection

December 3, 2021
Medical Communications

The Pfizer and Moderna booster vaccines have been shown to provide the best overall boost response, according to a UK …

News

WHO say Delta measures will help fight Omicron

December 3, 2021
Medical Communications

WHO officials have shared that COVID-19 health measures taken prior to the emergence of Omicron will also help combat the …

News

Researchers develop blood test for HPV-associated head and neck cancer

December 3, 2021
Medical Communications

A new blood test developed by researchers at Mass Eye and Ear and Mass General Hospital have developed a more …

News

ARASENS Phase III trial for prostate cancer treatment meets primary endpoint

December 3, 2021
Medical Communications

Orion and Bayer’s Phase III ARASENS trial has demonstrated an increase in overall survival, evaluating darolutamide in combination with docetaxel …

News

QIAGEN announces CE marking of T-cell response measuring device

December 2, 2021
Business Services

QIAGEN has launched a CE-marked version of its QuantiFEROn SARS-CoV-2 assay, which measures T-cell responses to SARS-CoV-2, and aids in …

News

UK regulator approves antibody drug which may help tackle Omicron

December 2, 2021
Research and Development

UK drug regulators have approved Xevudy (sotrovimab), a new coronavirus antibody treatment made by GlaxoSmithKline (GSK), which has been found …

News

EU bring forward launch of COVID-19 vaccine for children

December 1, 2021
Research and Development

The rollout of Pfizer and BioNTech’s COVID-19 vaccine version for children aged five to 11 years old will begin on …

News

UK Health Secretary Javid urges for more COVID-19 tests amid rising Omicron cases and vaccine developments

December 1, 2021
Research and Development

Health secretary of the UK, Sajid Javid, has urged the public to take lateral flow tests before attending parties this …

News

FDA approves new drug for identification of ovarian cancer

November 30, 2021
Manufacturing and Production

The FDA announced the approval of pafolacianine, marketed as Cytalux, a new drug which could help doctors detect ovarian cancer …

News

FDA plans fast approvals for Omicron-targeting vaccines

November 30, 2021
Manufacturing and Production

Joe Biden has directed the FDA and CDC to respond quickly to applications for vaccines or boosters to shield against …

News

NICE recommends Tagrisso (osimertinib) in England for lung cancer patients

November 30, 2021
Manufacturing and Production

AstraZeneca have announced that Tagrisso (osimertinib) is now available as an adjuvant treatment option to patients in England with completely …

News

Vaccine makers pledge to develop Omicron-effective jab

November 29, 2021
Sales and Marketing

Leading vaccine producers have shared that they are already pursuing vaccine responses to the newly-discovered coronavirus variant, Omicron. BioNTech has …

News

Nottinghamshire school sets up targeted testing for Omicron

November 29, 2021
Sales and Marketing

A school in Nottingham has set up targeted testing after a case of the new COVID-19 variant, Omicron, was detected …

News
mufid-majnun-oi20ehignd4-unsplash

WHO: unclear if Omicron causes severe disease

November 29, 2021
Sales and Marketing

WHO has shared that it is still unclear whether the recently-detected coronavirus variant Omicron is more transmissible, or causes more …

News

FDA approves AI-based breast cancer screening software MammoScreen®

November 29, 2021
Sales and Marketing

The FDA has approved MammoScreen®, Therapixel’s explainable and actionable Artificial Intelligence (AI) based software assisting Radiologists in breast cancer screening. …

News

New COVID-19 variant in South Africa as massive surge in Europe infections

November 26, 2021
Medical Communications

A new variant of coronavirus found in South Africa is feared to be more transmissible than other strains, and poses …

News

Allorion gains $40 million funding to enhance and discover precision targets

November 26, 2021
Medical Communications

Allorion Therapeutics has announced that they have gained $40 million in Series A financing. The funding was led by Chinese …

News

US government expands COVID-19 booster eligibility ahead of holidays

November 25, 2021
Business Services

The Biden administration has expanded COVID-19 booster eligibility, and millions of Americans have received their booster shots at a near …

News

Groundbreaking success shown in target drug combination for aggressive brain tumours

November 25, 2021
Business Services

A combination of two targeted cancer drugs have shown unprecedented activity in patients with highly malignant brain tumours carrying a …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026